Ballymore Resources (ASX: BMR) extends Torpy’s high-grade silver system as 20 drill assays remain pending
Read More Healthcare Industry News Why CONMED’s (NYSE: CNMD) reported sale review could reset the medtech value debate after Q2 CONMED’s sale speculation, Q2 results and AirSeal update put CNMD back in focus. Read how medtech M&A interest could reshape its turnaround story. bySrinathAugust 1, 2026